Important COVID-19 Information for Cancer Patients. READ NOW
Now Offering Phone and Video Appointments for Cancer Care
Anshu Giri, MD, MS
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
About
Assistant Professor, Department of Hematology/Oncology
Specialties
Treatment Philosophy
For a cancer patient the ideal treatment maximizes quality of life, while minimizing side effects. My philosophy as an oncologist is to guide the patient toward achieving this goal. I strive to ensure that patients and their families have a comprehensive understanding of their disease and available treatment options. In addition, I believe a patient deserves to be treated functionally, emotionally, and socially, as a whole person. By being a part of Fox Chase Cancer Center, I will be working with a team devoted to making this happen.
After completing my fellowship at the Medical University of South Carolina, I am excited to join Fox Chase and the vibrant medical community in Philadelphia. I was immediately impressed by the collegiality of the faculty and staff, as well as the multidisciplinary approach to their care. I am enthusiastic about being involved in the treatment of a variety of solid tumors.
Education and Training
Educational Background
- Hematology Oncology Fellowship, Medical University of South Carolina, Charleston, SC, 2016-2019
- Internal Medicine Residency, Upstate Medical University, Syracuse, NY, 2013-2016
- MD, St. George’s University, Grenada, 2009-2013
- MS, Medical Sciences, Wayne State University, Detroit, MI, 2006-2008
- BS, Chemistry, University of Michigan, Ann Arbor, MI, 2003-2006
Certifications
- American Board of Internal Medicine, 2016
- American Board of Medical Oncology, 2019
- American Board of Hematology, 2019
- BLS and ACLS
Memberships
- American Society of Clinical Oncology
- American Society of Hematology
Publications
Selected Publications
Giri, A., Walia, SS., Gajra, A. Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer. Rev Recent Clin Trials. 2016, Jul 24.
Pinto, I., Giri, A., Arshad, U., Gajra, A. New Oral Anticoagulants and Their Reversal. Current Drug Safety. 2015; 10 (3): 208-16.
Aleksiejuk, P., Pawar, L., Giri, A.. Conservative Management of Spontaneous Esophageal Perforation in a Patient with Achalasia. Critical Care Medicine. 2014, Dec; 42(12): A1660.
Giri, A., Goustin, A.S., Wang, S., Al-Katib, A., Mohammad, R.. Surface plasmon resonance study of apoptotic regulators Bcl-2, Bcl-w, Bcl-XL, Mcl-1 and A1 and the small molecule inhibitor (SMI) TW-37: the idea of a temporal window for drug activity. Cancer Research. 2008, May; 68(9S): 3192.
Mohammad, R., Giri, A., Goustin, A. S.. Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer. Recent patents on anti-cancer drug discovery. 2008, Jan; 3(1): 20-30.
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Assistant Professor, Department of Hematology/Oncology
Specialties
Treatment Philosophy
For a cancer patient the ideal treatment maximizes quality of life, while minimizing side effects. My philosophy as an oncologist is to guide the patient toward achieving this goal. I strive to ensure that patients and their families have a comprehensive understanding of their disease and available treatment options. In addition, I believe a patient deserves to be treated functionally, emotionally, and socially, as a whole person. By being a part of Fox Chase Cancer Center, I will be working with a team devoted to making this happen.
After completing my fellowship at the Medical University of South Carolina, I am excited to join Fox Chase and the vibrant medical community in Philadelphia. I was immediately impressed by the collegiality of the faculty and staff, as well as the multidisciplinary approach to their care. I am enthusiastic about being involved in the treatment of a variety of solid tumors.
Education
Educational Background
- Hematology Oncology Fellowship, Medical University of South Carolina, Charleston, SC, 2016-2019
- Internal Medicine Residency, Upstate Medical University, Syracuse, NY, 2013-2016
- MD, St. George’s University, Grenada, 2009-2013
- MS, Medical Sciences, Wayne State University, Detroit, MI, 2006-2008
- BS, Chemistry, University of Michigan, Ann Arbor, MI, 2003-2006
Certifications
- American Board of Internal Medicine, 2016
- American Board of Medical Oncology, 2019
- American Board of Hematology, 2019
- BLS and ACLS
Memberships
- American Society of Clinical Oncology
- American Society of Hematology
Publications
Selected Publications
Giri, A., Walia, SS., Gajra, A. Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer. Rev Recent Clin Trials. 2016, Jul 24.
Pinto, I., Giri, A., Arshad, U., Gajra, A. New Oral Anticoagulants and Their Reversal. Current Drug Safety. 2015; 10 (3): 208-16.
Aleksiejuk, P., Pawar, L., Giri, A.. Conservative Management of Spontaneous Esophageal Perforation in a Patient with Achalasia. Critical Care Medicine. 2014, Dec; 42(12): A1660.
Giri, A., Goustin, A.S., Wang, S., Al-Katib, A., Mohammad, R.. Surface plasmon resonance study of apoptotic regulators Bcl-2, Bcl-w, Bcl-XL, Mcl-1 and A1 and the small molecule inhibitor (SMI) TW-37: the idea of a temporal window for drug activity. Cancer Research. 2008, May; 68(9S): 3192.
Mohammad, R., Giri, A., Goustin, A. S.. Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer. Recent patents on anti-cancer drug discovery. 2008, Jan; 3(1): 20-30.